Which health influencers are most reliable on Weight Loss & Fat Loss?

Our expert leaderboard ranks influencers by accuracy on Weight Loss & Fat Loss claims, verified against peer-reviewed studies.

Health topic

Weight Loss & Fat Loss

Evidence-based approaches to sustainable fat loss including nutrition, exercise, supplements, and metabolic optimization.

Key findings

{"title":"GLP-1 Agonists Cause Disproportionate Muscle Loss — Up to 40% of Weight Lost May Be Lean Mass","detail":"A 2023 analysis in Nature Medicine of semaglutide trials found that approximately 30-40% of weight lost on GLP-1 receptor agonists was lean body mass, not fat. This has sparked urgent research into whether concurrent resistance training and high protein intake can mitigate this effect, with the STEP 8 extension trial showing concerning bone density reductions as well. The finding challenges the narrative that these drugs are a simple solution to obesity.","study_type":"RCT","year":"2023","source":"Nature Medicine","source_url":"https://doi.org/10.1038/s41591-023-02597-w","participants":"1961","surprise_factor":"High","tier":"Paradigm Shifting"}
{"title":"Retatrutide (Triple Agonist GIP/GLP-1/Glucagon) Achieves 24% Body Weight Loss — Approaching Bariatric Surgery Territory","detail":"A phase 2 RCT published in the New England Journal of Medicine in 2023 showed that retatrutide, which simultaneously activates GIP, GLP-1, and glucagon receptors, produced up to 24.2% weight loss at 48 weeks. This triple-hormone approach represents a fundamentally new pharmacological paradigm, with the glucagon component potentially increasing energy expenditure rather than just suppressing appetite. Phase 3 trials are underway.","study_type":"RCT","year":"2023","source":"New England Journal of Medicine","source_url":"https://doi.org/10.1056/NEJMoa2301972","participants":"338","surprise_factor":"High","tier":"Cutting Edge"}
{"title":"Bimagrumab (Myostatin Pathway Blocker) Causes Fat Loss While Simultaneously Building Muscle — Breaking the Recomposition Barrier","detail":"A 2021 RCT in JAMA Network Open tested bimagrumab, an activin type II receptor antibody, in obese adults with type 2 diabetes. Participants lost 20.5% of fat mass while gaining 3.6% lean mass over 48 weeks — achieving true body recomposition without exercise intervention. This anti-myostatin approach is now being explored in combination with GLP-1 agonists to counteract their muscle-wasting effects, generating intense interest in biohacking communities.","study_type":"RCT","year":"2021","source":"JAMA Network Open","source_url":"https://doi.org/10.1001/jamanetworkopen.2020.33457","participants":"75","surprise_factor":"High","tier":"Cutting Edge"}
{"title":"Succinate Released During Exercise Directly Activates Brown Fat Thermogenesis — A New Fat-Burning Pathway","detail":"A 2018 study in Nature by Mills et al. discovered that the metabolite succinate accumulates in the bloodstream during exercise and is taken up by brown adipose tissue, where it drives thermogenesis through reactive oxygen species signaling. This finding reveals a previously unknown molecular link between muscle activity and fat burning that operates independently of the sympathetic nervous system. Biohackers are now exploring whether cold exposure combined with exercise amplifies this pathway.","study_type":"Lab Study","year":"2018","source":"Nature","source_url":"https://doi.org/10.1038/s41586-018-0353-2","participants":null,"surprise_factor":"High","tier":"Paradigm Shifting"}
{"title":"Sleep-Deprived Dieters Lose 55% Less Fat and 60% More Muscle — Even With Identical Calorie Deficits","detail":"The landmark Nedeltcheva et al. RCT placed participants on identical caloric deficits but varied sleep from 8.5 to 5.5 hours. The sleep-deprived group lost dramatically more lean mass and less fat, with elevated ghrelin and reduced resting metabolic rate. This study fundamentally reframes sleep as a fat-loss intervention rather than merely a recovery tool, suggesting that optimizing sleep may be more impactful than fine-tuning macros.","study_type":"RCT","year":"2010","source":"Annals of Internal Medicine","source_url":"https://doi.org/10.7326/0003-4819-153-7-201010050-00006","participants":"10","surprise_factor":"Medium","tier":"Emerging Validation"}
{"title":"5-Amino-1MQ: A Novel NNMT Inhibitor That Reduces Fat Cell Size Without Caloric Restriction in Animal Models","detail":"Nicotinamide N-methyltransferase (NNMT) inhibitors like 5-amino-1MQ are generating significant buzz in longevity and biohacking circles. Preclinical studies show NNMT is overexpressed in adipose tissue of obese individuals, and its inhibition in mouse models reduced body weight and fat mass while increasing NAD+ levels and energy expenditure. No human RCTs exist yet, but the compound is widely discussed on longevity forums and available through research chemical suppliers.","study_type":"Lab Study","year":"2020","source":"Biochemical Pharmacology","source_url":"https://doi.org/10.1016/j.bcp.2020.114005","participants":null,"surprise_factor":"High","tier":"Cutting Edge"}
{"title":"Biggest Loser Contestants Still Had Suppressed Metabolisms 6 Years Later — Adaptive Thermogenesis Is Persistent","detail":"Fothergill et al. tracked 14 Biggest Loser contestants and found that six years after the competition, their metabolic rates were still ~500 kcal/day lower than expected for their body size. Crucially, those who regained the most weight had the greatest persistent metabolic suppression, suggesting the body 'remembers' its highest weight. This challenges the assumption that metabolic adaptation fully reverses with weight regain and has implications for GLP-1 drug discontinuation.","study_type":"Prospective Study","year":"2016","source":"Obesity","source_url":"https://doi.org/10.1002/oby.21538","participants":"14","surprise_factor":"Medium","tier":"Paradigm Shifting"}
{"title":"Early Time-Restricted Eating Improves Insulin Sensitivity and Fat Oxidation Even Without Weight Loss","detail":"Sutton et al.'s 2018 crossover RCT had prediabetic men eat within a 6-hour early window (finishing dinner by 3 PM) versus a 12-hour window. Despite no weight loss, the early eating group showed dramatically improved insulin sensitivity, beta cell function, and blood pressure. A 2022 NEJM RCT by Liu et al. with 139 participants confirmed that calorie restriction combined with time-restricted eating produced greater weight loss than calorie restriction alone.","study_type":"RCT","year":"2018","source":"Cell Metabolism","source_url":"https://doi.org/10.1016/j.cmet.2018.04.010","participants":"8","surprise_factor":"Medium","tier":"Emerging Validation"}
{"title":"Gut Microbiome Composition Predicts Individual Weight Loss Response to Identical Diets","detail":"A 2021 study in mSystems by Grembi et al. from Stanford found that baseline gut microbiome profiles predicted who would lose weight on a high-fiber diet versus a calorie-restricted diet. Specifically, higher Prevotella-to-Bacteroides ratios predicted better outcomes on fiber-rich diets. A 2023 Nature Medicine study further showed that Akkermansia muciniphila abundance correlated with metabolic improvements after dietary intervention, suggesting microbiome testing could personalize weight loss strategies.","study_type":"Prospective Study","year":"2021","source":"mSystems","source_url":"https://doi.org/10.1128/mSystems.00115-21","participants":"61","surprise_factor":"Medium","tier":"Paradigm Shifting"}
{"title":"Tesofensine (Triple Monoamine Reuptake Inhibitor) Produced 12.8% Weight Loss in Phase 2 — Outperforming All Drugs Available at the Time","detail":"Originally developed for Parkinson's and Alzheimer's, tesofensine inhibits reuptake of norepinephrine, dopamine, and serotonin simultaneously. A 2008 Lancet phase 2 trial showed 12.8% weight loss at the highest dose over 24 weeks, driven by appetite suppression and modest increases in energy expenditure. After years of regulatory delays, it is now in phase 3 trials in certain markets and is discussed extensively in biohacking communities as a potential alternative to GLP-1 drugs.","study_type":"RCT","year":"2008","source":"The Lancet","source_url":"https://doi.org/10.1016/S0140-6736(08)61525-1","participants":"203","surprise_factor":"High","tier":"Cutting Edge"}
{"title":"Wearable-Validated Data Shows Non-Exercise Activity Thermogenesis (NEAT) Varies by 2,000 kcal/Day Between Individuals","detail":"Levine et al.'s foundational work, now being confirmed by continuous accelerometry from wearables, shows that fidgeting, posture changes, and spontaneous physical activity account for enormous caloric differences between people. A 2023 analysis using research-grade wearables confirmed that NEAT unconsciously decreases during caloric restriction — the body moves less without the person realizing it. This 'constrained energy' model, championed by Pontzer's 2021 work in Current Biology, suggests exercise calories are partially compensated by reduced NEAT.","study_type":"Observational","year":"2023","source":"Current Biology","source_url":"https://doi.org/10.1016/j.cub.2021.01.005","participants":"1754","surprise_factor":"Medium","tier":"Emerging Validation"}
{"title":"Adipose Tissue Macrophage Reprogramming: Exercise Switches Fat Inflammation from M1 to M2 Phenotype Independent of Weight Loss","detail":"Building on the landmark Weisberg and Xu 2003 findings that obesity fills fat tissue with inflammatory macrophages, a 2012 study by Kawanishi et al. demonstrated that exercise training shifted adipose tissue macrophages from pro-inflammatory M1 to anti-inflammatory M2 phenotype — even without significant weight loss. This suggests exercise's metabolic benefits operate partly through immune cell reprogramming in fat tissue, a mechanism distinct from caloric expenditure.","study_type":"Lab Study","year":"2012","source":"PLOS ONE","source_url":"https://consensus.app/papers/exercise-training-inhibits-inflammation-in-adipose-kawanishi-yano/b478d2de7bb25b04bb7d6d8e671d4a93/?utm_source=publicapi","participants":null,"surprise_factor":"Medium","tier":"Paradigm Shifting"}

Evidence-based recommendations

Establish a moderate caloric deficit of 300–500 kcal/day (roughly 0.5–1% of body weight lost per week) rather than aggressive restriction, which triggers greater metabolic adaptation and muscle loss. Use a food tracking app for the first 4–6 weeks to build awareness, then transition to intuitive portion control.
Consume 1.6–2.2 g protein per kg body weight daily, distributed across 3–5 meals with at least 30–40g per meal to maximize muscle protein synthesis. Prioritize whole food sources (chicken, fish, eggs, Greek yogurt, legumes) and supplement with whey protein isolate only when needed to hit targets.
Perform resistance training 3–4× per week focusing on compound movements (squats, deadlifts, rows, presses) with progressive overload. This is non-negotiable for preserving lean mass during a deficit and is more important for body composition than any form of cardio.
Walk 8,000–10,000 steps daily as your primary 'cardio' — this increases NEAT by 200–500 kcal/day without triggering compensatory hunger. Add 1–2 sessions of moderate-intensity cardio (zone 2) per week for cardiovascular health, not as a primary fat loss tool.

Our analysis

The foundational science of fat loss is remarkably settled: caloric deficit drives weight loss regardless of macronutrient composition (Sacks et al., 2009), resistance training with adequate protein preserves lean mass during that deficit (Cava et al., 2017; Longland et al., 2016), and sleep deprivation dramatically shifts the composition of weight lost toward muscle rather than fat (Nedeltcheva et al., 2010). These pillars are supported by decades of replicated RCTs. What's equally well-established but often overlooked is that metabolic adaptation is real, persistent, and not fully explained by changes in body mass — the Biggest Loser study showed suppressed metabolisms lasting at least six years. The research frontier is exploding in several directions simultaneously. The GLP-1 revolution has opened a Pandora's box: drugs like semaglutide and the incoming triple agonist retatrutide are achieving weight loss previously only seen with bariatric surgery, but the muscle loss problem is severe and largely unaddressed. This has created intense interest in combination approaches — pairing GLP-1 drugs with myostatin pathway inhibitors like bimagrumab, or with resistance training protocols specifically designed to counteract lean mass loss. Meanwhile, the microbiome's role in individual diet response is moving from speculation to prediction, with baseline gut profiles now showing real predictive power for which dietary approach will work for a given person. Chrono-nutrition resear…

Frequently asked questions

What does the science say about Weight Loss & Fat Loss?: Evidence-based approaches to sustainable fat loss including nutrition, exercise, supplements, and metabolic optimization.
Which health influencers are most reliable on Weight Loss & Fat Loss?: Our expert leaderboard ranks influencers by accuracy on Weight Loss & Fat Loss claims, verified against peer-reviewed studies.

All health topics